Chemed Corp. (CHE) Earning Positive Press Coverage, Study Finds

News stories about Chemed Corp. (NYSE:CHE) have trended positive on Monday, according to AlphaOne Sentiment. AlphaOne, a subsidiary of Accern, identifies negative and positive media coverage by reviewing more than twenty million news and blog sources in real time. AlphaOne ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Chemed Corp. earned a media sentiment score of 0.34 on AlphaOne’s scale. AlphaOne also assigned headlines about the company an impact score of 0 out of 100, indicating that recent media coverage is extremely unlikely to have an effect on the stock’s share price in the near future.

Insider Buying and Selling by Quarter for Chemed Corp. (NYSE:CHE)

Chemed Corp. (NYSE:CHE) traded up 0.77% during midday trading on Monday, hitting $208.22. 85,537 shares of the company were exchanged. Chemed Corp. has a one year low of $126.54 and a one year high of $216.01. The firm’s 50-day moving average price is $204.48 and its 200-day moving average price is $180.38. The stock has a market capitalization of $3.35 billion, a PE ratio of 30.55 and a beta of 1.17.

Chemed Corp. (NYSE:CHE) last issued its quarterly earnings data on Wednesday, April 26th. The company reported $1.82 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.78 by $0.04. The business had revenue of $405.90 million for the quarter, compared to analysts’ expectations of $399.75 million. Chemed Corp. had a return on equity of 24.62% and a net margin of 7.14%. The company’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.62 EPS. Equities research analysts anticipate that Chemed Corp. will post $7.95 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 14th. Stockholders of record on Thursday, May 25th were issued a dividend of $0.26 per share. The ex-dividend date was Tuesday, May 23rd. This represents a $1.04 annualized dividend and a dividend yield of 0.50%. Chemed Corp.’s dividend payout ratio (DPR) is 15.25%.

Separately, Zacks Investment Research lowered shares of Chemed Corp. from a “buy” rating to a “hold” rating in a research report on Tuesday, May 2nd.

COPYRIGHT VIOLATION NOTICE: This article was originally published by BBNS and is the property of of BBNS. If you are reading this article on another publication, it was illegally stolen and republished in violation of United States & international copyright and trademark law. The correct version of this article can be read at https://baseballnewssource.com/markets/chemed-che-receives-news-sentiment-rating-of-0-34-updated-updated-updated/804154.html.

In other news, insider Kevin J. Mcnamara sold 4,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 2nd. The stock was sold at an average price of $205.11, for a total transaction of $820,440.00. Following the sale, the insider now directly owns 148,943 shares of the company’s stock, valued at approximately $30,549,698.73. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Donald E. Saunders sold 400 shares of the company’s stock in a transaction that occurred on Wednesday, May 3rd. The stock was sold at an average price of $204.85, for a total value of $81,940.00. Following the sale, the director now directly owns 9,886 shares in the company, valued at $2,025,147.10. The disclosure for this sale can be found here. Insiders have sold a total of 5,400 shares of company stock worth $1,104,850 over the last ninety days. Insiders own 5.32% of the company’s stock.

Chemed Corp. Company Profile

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with our FREE daily email newsletter.

 


Latest News

Tigers Decline Means Justin Verlander Could be on the Block
Tigers Decline Means Justin Verlander Could be on the Block
Miami Marlins Trade Adeiny Hechavarria to Tampa Bay
Miami Marlins Trade Adeiny Hechavarria to Tampa Bay
Baltimore Orioles Pitching Staff Continue to Fail
Baltimore Orioles Pitching Staff Continue to Fail
Cody Bellinger Continues Strong June at the Plate
Cody Bellinger Continues Strong June at the Plate
Hitters in Major League Baseball on Record Home Run Pace
Hitters in Major League Baseball on Record Home Run Pace
Atlanta Considering Playing Freddie Freeman at Third
Atlanta Considering Playing Freddie Freeman at Third


Leave a Reply

 
© 2006-2017 BBNS.